Evidence map›Paper›PMID 39642865›Full record

ArticleCell stem cell2024

Self-organization of the hematopoietic vascular niche and emergent innate immunity on a chip.

Andrei Georgescu, Joseph Hai Oved, Jonathan H Galarraga, Thomas Cantrell, Samira Mehta, Brian M Dulmovits, Timothy S Olson, Pouria Fattahi, Anni Wang, Pelin L Candarlioglu and 8 more

Abstract read
In one paragraph

Article in Cell stem cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Organ-on-a-chip toxicology.Innovation (Cambridge (Mass.)) · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Andrei GeorgescuDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA; Vivodyne Inc., Philadelphia, PA 19104, USA.
Joseph Hai OvedDivision of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jonathan H GalarragaVivodyne Inc., Philadelphia, PA 19104, USA.
Thomas CantrellVivodyne Inc., Philadelphia, PA 19104, USA.
Samira MehtaDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Brian M DulmovitsBlood and Marrow Transplant Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA.
Timothy S OlsonBlood and Marrow Transplant Program, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pouria FattahiDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Anni WangDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Pelin L CandarliogluComplex In Vitro Models, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
Asli MuvaffakComplex In Vitro Models, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
Michele M KimDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Sezin Aday AydinDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Jeongyun SeoDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Eric S DiffenderferDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Anthony LynchComplex In Vitro Models, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
G Scott WorthenDivision of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, PA 19104, USA. Electronic address: worthen@chop.edu.
Dan Dongeun HuhDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA; Vivodyne Inc., Philadelphia, PA 19104, USA; Center for Innovation & Precision Dentistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; NSF Science and Technology Center for Engineering Mechanobiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: huhd@seas.upenn.edu.

Funding

Institutional Clinical and Translational Science AwardKL2TR001879 · NCATS · UNIVERSITY OF PENNSYLVANIA · PI MEAGHER, EMMA ANNE · 2016 to 2025
$13.7M
Probing the physics of chronic lung disease using microphysiological biomimicryDP2HL127720 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HUH, DONGEUN · 2014 to 2014
$2.4M
Lung Host Defense in MicrogravityUG3TR002198 · NCATS · CHILDREN'S HOSP OF PHILADELPHIA · PI HUH, DONGEUN, WORTHEN, GEORGE SCOTT · 2017 to 2018
$1.4M
NCATS NIH HHS KL2 TR001879NCATS NIH HHS UG3 TR002198NHLBI NIH HHS DP2 HL127720
6 · The paper itself

Abstract

Here, we present a bioengineering approach to emulate the human bone marrow in vitro. Our developmentally inspired method uses self-organization of human hematopoietic stem and progenitor cells and vascular endothelial cells cultured in a three-dimensional microphysiological system to create vascularized, perfusable tissue constructs that resemble the hematopoietic vascular niche of the human marrow. The microengineered niche is capable of multilineage hematopoiesis and can generate functionally mature human myeloid cells that can intravasate into perfused blood vessels, providing a means to model the mobilization of innate immune cells from the marrow. We demonstrate the application of this system by presenting a specialized model of ionizing radiation-induced bone marrow injury and a multiorgan model of acute innate immune responses to bacterial lung infection. Furthermore, we introduce an advanced platform that enables large-scale integration and automated experimentation of the engineered hematopoietic tissues for preclinical screening of myelotoxicity due to anti-cancer drugs.

Indexed as

Hematopoietic Stem CellsImmunity, InnateAnimalsHematopoiesisHumansLab-On-A-Chip DevicesStem Cell NicheTissue Engineeringbone marrowdrug testinghematopoiesishematopoietic stem cellsimmune cellsin vitro modelslung-on-a-chipmicrophysiological systemsmyelosuppresionorgan-on-a-chip

Identifiers

PMID39642865
PMCPMC11651161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.